Informations sur le produit
- 1,1-Dioxo-6-(trifluoromethyl)-1,2,3,4-tetrahydro-1λ6,2,4-benzothiadiazine-7-sulfonamide
- 1,1-Dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1λ6,2,4-benzothiadiazine-7-sulfonamide
- 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-6-(trifluoromethyl)-, 1,1-dioxide
- 3,4-Dihydro-6-(trifluoromethyl)-2H-1,2,4-
- 3,4-Dihydro-6-trifluoromethyl-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
- 3,4-Dihydro-6-trifluoromethyl-2H-1,2,4-benzothiazide-7-sulfonamide 1,1-dioxide
- 3,4-Dihydro-6-trifluoromethyl-7-sulfamoylbenzo-1,2,4-thiadiazine 1,1-dioxide
- 3,4-Dihydro-7-sulfamoyl-6-trifluoromethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide
- 3,4-Dihydro-7-sulfamyl-6-trifluoromethyl-1,2,4-benzothiadiazine 1,1-dioxide
- 3,4-Dihydro-7-sulfamyl-6-trifluoromethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide
- Voir d'autres synonymes
- 6-(trifluoromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
- 6-Trifluoromethyl-3,4-dihydro-7-sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide
- 6-Trifluoromethyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide
- 7-Sulfamyl-6-trifluoromethyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide
- Benzothiodiazine(2H-1,2,4)-7-Sulfonamide, 3,4-Dihydro-6-Trifluoromethyl)-1,1-Dioxide
- Bristab
- Bristurin
- Di-Ademil
- Dihydroflumethiazide
- Diucardin
- Diumide K
- Diuredemina
- Diurometon
- Elodrine
- Finuret
- Flutizide
- Glomerulin
- Hidroalogen
- Hidroflumetiazid
- Hidroflumetiazida
- Hydol
- Hydrenox
- Hydroflumethiazid
- Leodrine
- Metflorylthiazidine
- Methforylthiazidine
- NaClex
- NaClex (Glaxo)
- Nsc 44627
- Olmagran
- Rodiuran
- Rontyl
- Saluron
- Salutensin
- Sisuril
- Spandiuril
- Trifluoromethylhydrothiazide
- Vergonil
Hydroflumethiazide is a diuretic drug that is used to treat high blood pressure, heart failure, and edema. It decreases the production of aqueous humor by the eye, thereby decreasing intraocular pressure. Hydroflumethiazide also inhibits sodium reabsorption in the loop of Henle and helps to control hypertension. The drug increases renal excretion of water and electrolytes, which can lead to dehydration. Hydroflumethiazide has been shown to have an adverse effect on cardiovascular function due to its ability to inhibit ATP channels in cardiac cells and interfere with glomerular filtration rate (GFR). It has also been found to increase matrix metalloproteinases (MMP) activity in inflammatory bowel disease patients.
Propriétés chimiques
Question d’ordre technique sur : 3D-AAA13509 Hydroflumethiazide
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages